| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
158,685 |
135,595 |
$37.02M |
| G9012 |
Other specified case management service not elsewhere classified |
1,342 |
1,107 |
$230K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
9,985 |
9,114 |
$64K |
| 3074F |
|
4,427 |
4,264 |
$41K |
| 3078F |
|
4,572 |
4,364 |
$38K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
47,494 |
43,960 |
$28K |
| 3079F |
|
2,921 |
2,824 |
$24K |
| 3077F |
|
3,049 |
2,926 |
$21K |
| 3075F |
|
2,162 |
2,102 |
$17K |
| 3044F |
|
1,539 |
1,532 |
$13K |
| 3080F |
|
1,598 |
1,552 |
$12K |
| 3046F |
|
584 |
576 |
$5K |
| 3051F |
|
534 |
532 |
$5K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
146 |
141 |
$5K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
162 |
153 |
$4K |
| 3052F |
|
415 |
406 |
$3K |
| 0502F |
|
766 |
516 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,407 |
13,087 |
$2K |
| 90734 |
|
317 |
316 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
16,076 |
14,501 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
9,445 |
7,399 |
$1K |
| 90688 |
|
171 |
153 |
$966.14 |
| 90670 |
|
707 |
706 |
$880.64 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,049 |
2,036 |
$812.45 |
| 99499 |
|
27 |
27 |
$567.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,288 |
2,271 |
$560.32 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,604 |
1,592 |
$520.32 |
| 90715 |
|
1,537 |
1,528 |
$480.51 |
| 90686 |
|
5,410 |
5,386 |
$370.49 |
| 92015 |
Determination of refractive state |
130 |
126 |
$291.00 |
| 90710 |
|
54 |
54 |
$280.00 |
| 99442 |
|
835 |
794 |
$278.76 |
| 82962 |
|
6,366 |
6,206 |
$272.13 |
| 83655 |
|
1,767 |
1,753 |
$270.64 |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
8,140 |
7,015 |
$262.33 |
| 97802 |
|
708 |
662 |
$258.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,011 |
3,984 |
$170.90 |
| 90633 |
|
759 |
755 |
$109.51 |
| 90461 |
|
3,320 |
3,245 |
$83.78 |
| 99215 |
Prolong outpt/office vis |
2,080 |
2,047 |
$78.05 |
| D1110 |
Prophylaxis - adult |
95 |
88 |
$72.00 |
| 99384 |
|
319 |
317 |
$60.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
892 |
861 |
$53.87 |
| 90647 |
|
752 |
750 |
$53.28 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
472 |
472 |
$40.00 |
| 91321 |
|
15 |
14 |
$40.00 |
| 92552 |
|
5,263 |
5,226 |
$36.80 |
| 97035 |
|
5,528 |
5,066 |
$31.35 |
| 99177 |
|
2,049 |
2,027 |
$30.00 |
| 99173 |
|
5,274 |
5,236 |
$27.60 |
| D0140 |
Limited oral evaluation - problem focused |
149 |
148 |
$20.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
500 |
492 |
$12.70 |
| 96127 |
|
1,650 |
1,636 |
$10.80 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
815 |
794 |
$6.99 |
| 97014 |
|
7,986 |
7,068 |
$4.00 |
| G0127 |
Trimming of dystrophic nails, any number |
2,092 |
2,066 |
$3.66 |
| 85018 |
|
353 |
349 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
120 |
120 |
$0.00 |
| 99443 |
|
613 |
591 |
$0.00 |
| D0150 |
Comprehensive oral evaluation - new or established patient |
28 |
26 |
$0.00 |
| D1310 |
|
32 |
31 |
$0.00 |
| 1126F |
|
545 |
515 |
$0.00 |
| 96161 |
|
133 |
133 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
106 |
105 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
212 |
210 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
5,479 |
5,307 |
$0.00 |
| 97139 |
|
139 |
106 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
456 |
456 |
$0.00 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
2,265 |
1,880 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
84 |
83 |
$0.00 |
| 99496 |
|
64 |
62 |
$0.00 |
| 90677 |
|
671 |
668 |
$0.00 |
| 90723 |
|
667 |
666 |
$0.00 |
| 99383 |
|
256 |
255 |
$0.00 |
| 98943 |
|
461 |
390 |
$0.00 |
| 90619 |
|
412 |
410 |
$0.00 |
| 90696 |
|
27 |
27 |
$0.00 |
| 99000 |
|
121 |
121 |
$0.00 |
| 90732 |
|
110 |
109 |
$0.00 |
| 11055 |
|
80 |
77 |
$0.00 |
| 90656 |
|
271 |
270 |
$0.00 |
| D1206 |
Topical application of fluoride varnish |
52 |
52 |
$0.00 |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$0.00 |
| 99385 |
|
29 |
27 |
$0.00 |
| 99999 |
|
26 |
26 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
66 |
66 |
$0.00 |
| 99441 |
|
12 |
12 |
$0.00 |
| 90480 |
|
26 |
25 |
$0.00 |
| 0001A |
|
12 |
12 |
$0.00 |
| 90620 |
|
26 |
26 |
$0.00 |
| 1125F |
|
16 |
16 |
$0.00 |
| 91307 |
|
15 |
15 |
$0.00 |
| 90674 |
|
12 |
12 |
$0.00 |
| 1111F |
|
16 |
16 |
$0.00 |
| 99381 |
|
14 |
12 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
12 |
12 |
$0.00 |
| 83037 |
|
5,500 |
5,426 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
180 |
179 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
1,094 |
1,087 |
$0.00 |
| 90681 |
|
91 |
91 |
$0.00 |
| 11720 |
|
1,472 |
1,463 |
$0.00 |
| 99401 |
|
1,190 |
1,150 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,628 |
1,607 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
334 |
271 |
$0.00 |
| 97803 |
|
768 |
736 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
576 |
570 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,356 |
2,337 |
$0.00 |
| 3725F |
|
7,889 |
7,622 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
468 |
464 |
$0.00 |
| 81002 |
|
632 |
622 |
$0.00 |
| 11056 |
|
368 |
367 |
$0.00 |
| D0274 |
Bitewings - four radiographic images |
57 |
57 |
$0.00 |
| 99188 |
|
1,290 |
1,278 |
$0.00 |
| 98940 |
|
899 |
846 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
301 |
295 |
$0.00 |
| 90756 |
|
18 |
18 |
$0.00 |
| 90746 |
|
298 |
297 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
143 |
142 |
$0.00 |
| 99382 |
|
28 |
28 |
$0.00 |
| 1160F |
|
1,123 |
1,069 |
$0.00 |
| 90649 |
|
86 |
83 |
$0.00 |
| D1120 |
Prophylaxis - child |
76 |
76 |
$0.00 |
| 1159F |
|
1,116 |
1,066 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
141 |
117 |
$0.00 |
| D0220 |
Intraoral - periapical first radiographic image |
59 |
58 |
$0.00 |
| 2022F |
|
26 |
24 |
$0.00 |
| 11721 |
|
12 |
12 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
28 |
28 |
$0.00 |